# French National Assembly

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/french-national-assembly
Canonical HTML page: https://getbiobrief.com/entity/french-national-assembly

## Timeline

- **2026-07-15**: National Assembly gives final approval — Lower house votes 291-241 in favor of the assisted-dying bill after years of debate.
- **2022**: Macron commits to opening path for assisted dying — President Macron announces his intention to legislate on end-of-life options.

## Recent coverage (1 stories)

### France’s 291-241 Vote Opens a New Market for 300M+ Patients Worldwide
2026-08-01 08:50:09 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

France's historic vote to legalize assisted dying creates a new regulatory landscape for pharmaceutical companies developing end-of-life drugs. With 300 million people globally already having access, the French market offers opportunities for drug manufacturers, biotech firms, and palliative medicine innovators. Constitutional review awaits, but the pharma sector must prepare for evolving demand.
Full story: https://getbiobrief.com/story/france-assisted-dying-bill-biotech-market

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.